4-Amino-3-Chlorophenol CAS 17609-80-2 Lenvatinib Mesylate Intermediate Purity >99.0% (HPLC)
Ruifu Chemical Supply Lenvatinib Mesylate Intermediates With High Pure
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene)-2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Ingoa matū | 4-Amino-3-Cchlorophenol |
Nga kupu taurite | 3-Chloro-4-Aminophenol;Lenvaint-G |
Tau CAS | 17609-80-2 |
Tau CAT | RF-PI1968 |
Tūnga Taonga | I roto i te Stock, Production Tauine Up ki Taranata |
Tātai rāpoi | C6H6ClNO |
Taumaha rāpoi | 143.57 |
Kiato | 1.406±0.060 g/cm3 |
Waitohu | Ruifu Chemical |
Tūemi | Whakatakotoranga |
Te ahua | Paura Toka Paraone |
1 H NMR Spectrum | E rite ana ki te Hanganga |
Tautuhinga-HPLC | He rite te wa pupuri ki te paerewa |
Te Maama / Tikanga Tatauria | >99.0% (HPLC) |
Te Whakarewa | 138.0~141.0 ℃ |
Ngaronga i te whakamaroke | <1.00% |
Te toenga i runga i te mura | <0.30% |
Nga poke katoa | <1.00% |
Paerewa Whakamatau | Paerewa hinonga |
Whakamahinga | Takawaenga o Lenvatinib Mesylate (CAS: 857890-39-2) |
Mōkī: Pounamu, Peeke konumohe konumohe, 25kg / Kaata Drum, kia rite ranei ki te hiahia a te kaihoko
Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Tiaki i te marama me te makuku
Ko te 4-Amino-3-Chlorophenol (CAS: 17609-80-2) he takawaenga rongoa nui, e whakamahia nuitia ana i roto i te hoahoa me te whakahiato o te anti-tumor, nga mate cardiovascular, nga rongoa mate neurological.Ko te 4-Amino-3-Chlorophenol he takawaenga nui ki te whakarite i te Lenvatinib Mesylate (CAS: 857890-39-2).I whakawhanakehia e Eisai Inc., ko te lenvatinib mesylate he aukati vascular endothelial growth factor receptor (VEGF) he mahi ki te VEGF subtypes 1, 2, me 3 a i whakaaetia e te FDA i te tau 2015 mo te maimoatanga o te mate pukupuku thyroid rerekee kei te rohe. he auau, he metastatic, he ahu whakamua ranei, kaore i aro ki te maimoatanga iodine radioactive.I te marama o Haratua 2016, i whakaaetia e te FDA te rongoa hei rongoa whakakotahi me te everolimus mo te maimoatanga o te mate pukupuku o te pukupuku renal.Na te mea ko te VEGF (me nga kaiwhakawhiwhi take tipu fibroblast, e mohiotia ana ko FGFRs) e whakaarohia ana ka whai waahi ki nga huarahi tohu tohu cardiovascular, ko te VEGF2R me te aukati FGFR te whakaaro ko nga tikanga kei muri i te paanga tuatahi o te lenvatinib mesylate, ko te whakaheke toto.